AU2001218871A1 - Monoclonal antibody and method and kit for the immunoassay of soluble human st2 with the use of the same - Google Patents

Monoclonal antibody and method and kit for the immunoassay of soluble human st2 with the use of the same

Info

Publication number
AU2001218871A1
AU2001218871A1 AU2001218871A AU1887101A AU2001218871A1 AU 2001218871 A1 AU2001218871 A1 AU 2001218871A1 AU 2001218871 A AU2001218871 A AU 2001218871A AU 1887101 A AU1887101 A AU 1887101A AU 2001218871 A1 AU2001218871 A1 AU 2001218871A1
Authority
AU
Australia
Prior art keywords
immunoassay
kit
same
monoclonal antibody
soluble human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001218871A
Inventor
Takao Arai
Kenji Kuroiwa
Katsuhisa Oshikawa
Shin-Ichi Tominaga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical and Biological Laboratories Co Ltd
Original Assignee
TOMINAGA SHIN ICHI
Medical and Biological Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TOMINAGA SHIN ICHI, Medical and Biological Laboratories Co Ltd filed Critical TOMINAGA SHIN ICHI
Publication of AU2001218871A1 publication Critical patent/AU2001218871A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
AU2001218871A 2000-03-21 2000-12-07 Monoclonal antibody and method and kit for the immunoassay of soluble human st2 with the use of the same Abandoned AU2001218871A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-77383 2000-03-21
JP2000077383 2000-03-21
PCT/JP2000/008723 WO2001070817A1 (en) 2000-03-21 2000-12-07 Monoclonal antibody and method and kit for the immunoassay of soluble human st2 with the use of the same

Publications (1)

Publication Number Publication Date
AU2001218871A1 true AU2001218871A1 (en) 2001-10-03

Family

ID=18594962

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001218871A Abandoned AU2001218871A1 (en) 2000-03-21 2000-12-07 Monoclonal antibody and method and kit for the immunoassay of soluble human st2 with the use of the same

Country Status (3)

Country Link
US (1) US7087396B2 (en)
AU (1) AU2001218871A1 (en)
WO (1) WO2001070817A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002038794A2 (en) 2000-11-09 2002-05-16 The Brigham And Women's Hospital, Inc. Cardiovascular disease diagnostic and therapeutic targets
US7670769B2 (en) * 2002-05-09 2010-03-02 The Brigham And Women's Hospital, Inc. IL1RL-1 as a cardiovascular disease marker and therapeutic target
JP5383480B2 (en) * 2006-04-24 2014-01-08 クリティカル ケア ダイアグノスティクス インコーポレイテッド Predict fatality and detect serious disease
ATE517341T1 (en) * 2006-04-27 2011-08-15 Critical Care Diagnostics Inc INTERLEUKIN-33 (IL-33) FOR THE DIAGNOSIS AND PREDICTION OF CARDIOVASCULAR DISEASES
EP3059594A1 (en) 2006-05-01 2016-08-24 Critical Care Diagnostics, Inc. Prognosis of cardiovascular disease
PL2019965T3 (en) 2006-05-02 2015-10-30 Critical Care Diagnostics Inc Differential diagnosis between pulmonary and cardiovascular disease
US8147817B2 (en) 2006-05-04 2012-04-03 The Brigham And Women's Hospital, Inc. IL-33 in the treatment and diagnosis of diseases and disorders
PT2660599E (en) 2008-04-18 2014-11-28 Critical Care Diagnostics Inc Predicting risk of major adverse cardiac events
AU2016269576B2 (en) * 2010-04-09 2018-11-08 Critical Care Diagnostics, Inc. Soluble human ST-2 antibodies and assays
AU2013204182B2 (en) * 2010-04-09 2016-09-15 Critical Care Diagnostics, Inc. Soluble human ST-2 antibodies and assays
WO2011127412A2 (en) 2010-04-09 2011-10-13 Critical Care Diagnostics, Inc. Soluble human st-2 antibodies and assays
TW201238976A (en) 2011-02-23 2012-10-01 Hoffmann La Roche Antibodies against human IL33R and uses thereof
JP6215713B2 (en) 2011-03-17 2017-10-18 クリティカル ケア ダイアグノスティクス インコーポレイテッド How to predict the risk of adverse clinical outcomes
US9212227B2 (en) 2012-04-30 2015-12-15 Janssen Biotech, Inc. ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions
ES2709697T3 (en) 2012-05-18 2019-04-17 Critical Care Diagnostics Inc Procedures for treatment or prediction of the risk of a ventricular tachyarrhythmia event
JO3623B1 (en) 2012-05-18 2020-08-27 Amgen Inc St2 antigen binding proteins
CN107478841A (en) 2012-08-16 2017-12-15 重症监护诊断股份有限公司 The method of risk of hypertension is suffered from prediction
SG11201501271TA (en) 2012-08-21 2015-03-30 Critical Care Diagnostics Inc Multimarker risk stratification
WO2015164354A1 (en) 2014-04-21 2015-10-29 The Childen's Hospital Of Philadelphia Compositions and methods for treating cytokine-related disorders
CN104017057B (en) * 2014-06-27 2016-08-24 榆林市第一医院 A kind of ST2 protein inhibitor polypeptide and application thereof
CN104017056B (en) * 2014-06-27 2016-08-17 国科戎安生物科技（北京）有限公司 ST2 protein inhibitor polypeptide and application thereof
JP7231326B2 (en) 2014-11-10 2023-03-01 ジェネンテック， インコーポレイテッド Therapeutic and diagnostic methods for IL-33-mediated disorders
CR20170240A (en) 2014-11-10 2018-04-03 Genentech Inc ANTI-INTERLEUCINA-33 ANTIBODIES AND THEIR USES
US10079073B2 (en) 2014-12-11 2018-09-18 Critical Care Diagnostics, Inc. Test apparatus and methods for ST2 cardiac biomarker
US10324089B2 (en) 2014-12-11 2019-06-18 Critical Care Diagnostics, Inc. Test apparatus and methods for ST2 cardiac biomarker
CN110208549A (en) * 2019-07-01 2019-09-06 北京利德曼生化股份有限公司 A kind of Soluble growth stimulation 2 albumen sST2 luminescence reagent box of expressing gene
CN113214395A (en) * 2020-01-21 2021-08-06 迈威(上海)生物科技股份有限公司 anti-ST 2 antibodies and uses thereof
CN111308086B (en) * 2020-02-21 2022-02-25 苏州旭光科星抗体生物科技有限公司 Enzyme-linked immunoassay kit for detecting soluble ST2 content and application thereof
WO2021183849A1 (en) 2020-03-13 2021-09-16 Genentech, Inc. Anti-interleukin-33 antibodies and uses thereof
WO2023001257A1 (en) * 2021-07-21 2023-01-26 迈威(上海)生物科技股份有限公司 Anti-suppression of tumorigenicity 2 antibody and liquid composition containing same
CN117024595B (en) * 2023-10-08 2024-01-26 江西乐成欣生生物技术研究有限责任公司 Monoclonal antibody against human ST2 and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
DE19711932A1 (en) * 1997-03-21 1998-09-24 Anne Katrin Dr Werenskiold An in vitro method for predicting the course of disease of patients with breast cancer and / or for diagnosing a breast carcinoma

Also Published As

Publication number Publication date
WO2001070817A1 (en) 2001-09-27
US7087396B2 (en) 2006-08-08
US20030124624A1 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
AU2001218871A1 (en) Monoclonal antibody and method and kit for the immunoassay of soluble human st2 with the use of the same
AU5665696A (en) Novel methods for the assay of troponin i and t and complexe s of troponin i and t and selection of antibodies for use in immunoassays
AU2002220843A1 (en) Humanised antibodies and uses thereof
WO2002030986A3 (en) HUMANIZED ANTI-LT-β-R ANTIBODIES
IL156618A0 (en) Crystals of whole antibodies and fragments thereof, methods for the preparation thereof and diagnostic kits utilizing the same
AU1462300A (en) Human pan-hcv human monoclonal antibodies
AU2001278076A1 (en) Bstp-5 proteins and related reagents and methods of use thereof
AU2002338015A1 (en) Human CDR-grafted antibodies and antibody fragments thereof
AU5155398A (en) Anti-ccr5 antibodies and methods of use therefor
AU2002244968A1 (en) Anti-osteopontin antibody and use thereof
AU6618100A (en) Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus
AU2002340167A1 (en) Anti-hla-dr antibodies and the methods of using thereof
AU2001256325A1 (en) Human and humanized fap-alpha-specific antibodies
IL147517A0 (en) Monoclonal antibodies and immunoassay utilizing the same
AU7676300A (en) Human anti-adipocyte monoclonal antibodies and their use
AU7960600A (en) Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit
AU2001278011A1 (en) Bstp-ecg1 protein and related reagents and methods of use thereof
HUP0400697A3 (en) Silensed anti-cd28 antibodies and use thereof
AU2001294832A1 (en) Automated immunoassay analyzer and method of using the same
AU2002217212A1 (en) Method for preparing a human monoclonal antibody, fragments thereof or antibodies comprising such fragments, resulting antibodies and use thereof
AU2996100A (en) Activating film for chemiluminescent assays and methods for use
AU2002214333A1 (en) Method of assaying antilaminin-1 antibody and application thereof
AU2001284899A1 (en) Methods and universal monoclonal antibody array
AU2001267922A1 (en) Method of assaying the function of fc fragment of antibody
AU3257399A (en) Monoclonal antibodies esm-1 protein specific, and use of said antibodies for detecting esm-1 protein